Literature DB >> 19844242

Cyclooxygenase-1 and -2 differentially modulate lipopolysaccharide-induced blood-brain barrier disruption through matrix metalloproteinase activity.

Saba Aid1, Afonso C Silva, Eduardo Candelario-Jalil, Sang-Ho Choi, Gary A Rosenberg, Francesca Bosetti.   

Abstract

Cyclooxygenases (COX) -1 and -2 are key regulators of innate immune responses. We recently demonstrated that the expression of proinflammatory cytokines and chemokines is reduced in COX-1 null ((-/-)), and increased in COX-2(-/-) mice compared with their respective wild type controls during lipopolysaccharide (LPS)-induced innate immune activation. As chemokines are involved in leukocyte recruitment into the inflamed brain, we hypothesized that COX-1 and COX-2 deletion will differentially modulate blood-brain barrier (BBB) permeability in response to LPS. In the present study, using quantitative magnetic resonance imaging, we found that LPS-induced BBB disruption was exacerbated in COX-2(-/-) versus COX-2(+/+) mice. In the hippocampus and cortex of LPS-treated mice, matrix metalloproteinase (MMP)-3 activity was significantly decreased in COX-1(-/-) mice, whereas in COX-2(-/-) mice the activity of both MMP-9 and MMP-3, known to mediate BBB breakdown, was increased. Brain mRNA expression of the leukocyte attracting chemokine Cxcl10, the intercellular interaction molecule Icam-1, the pan-leukocyte marker Cd45 was increased in COX-2(-/-) versus COX-2(+/+) mice, whereas Cxcl10 and Cd45 mRNA expression was decreased in COX-1(-/-) versus COX-1(+/+) mice after LPS. Altogether, these results indicate that COX-2 activity modulates MMP-9 and-3 activities and is necessary to maintain BBB integrity during toll-like receptor 4-dependent innate immune activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19844242      PMCID: PMC2818570          DOI: 10.1038/jcbfm.2009.223

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  40 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia.

Authors:  N Laflamme; S Lacroix; S Rivest
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

3.  Modulatory role of cyclooxygenase-2 in cerebrovascular coupling.

Authors:  Bojana Stefanovic; Francesca Bosetti; Afonso C Silva
Journal:  Neuroimage       Date:  2006-04-19       Impact factor: 6.556

Review 4.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

5.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

6.  Toll-like receptor-4 regulation of hepatic Cyp3a11 metabolism in a mouse model of LPS-induced CNS inflammation.

Authors:  Kerry B Goralski; Dalya Abdulla; Christopher J Sinal; Andre Arsenault; Kenneth W Renton
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-05-05       Impact factor: 4.052

7.  Gene expression of cyclooxygenase-1 and Ca(2+)-independent phospholipase A(2) is altered in rat hippocampus during normal aging.

Authors:  Saba Aïd; Francesca Bosetti
Journal:  Brain Res Bull       Date:  2007-03-20       Impact factor: 4.077

8.  Lipopolysaccharide injected into the cerebral ventricle evokes fever through induction of cyclooxygenase-2 in brain endothelial cells.

Authors:  C Cao; K Matsumura; M Ozaki; Y Watanabe
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

9.  Protection of hippocampal neurogenesis from toll-like receptor 4-dependent innate immune activation by ablation of prostaglandin E2 receptor subtype EP1 or EP2.

Authors:  C Dirk Keene; Rubens Chang; Christina Stephen; Mary Nivison; Samuel E Nutt; Amy Look; Richard M Breyer; Phillip J Horner; Robert Hevner; Thomas J Montine
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

10.  Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.

Authors:  S Mun-Bryce; G A Rosenberg
Journal:  Am J Physiol       Date:  1998-05
View more
  29 in total

1.  Neuronal overexpression of cyclooxygenase-2 does not alter the neuroinflammatory response during brain innate immune activation.

Authors:  Saba Aid; Nishant Parikh; Sara Palumbo; Francesca Bosetti
Journal:  Neurosci Lett       Date:  2010-05-06       Impact factor: 3.046

Review 2.  Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications.

Authors:  Saba Aïd; Francesca Bosetti
Journal:  Biochimie       Date:  2010-09-22       Impact factor: 4.079

Review 3.  Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression.

Authors:  Michael Maes
Journal:  Metab Brain Dis       Date:  2012-07-07       Impact factor: 3.584

4.  Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus.

Authors:  G E Serrano; N Lelutiu; A Rojas; S Cochi; R Shaw; C D Makinson; D Wang; G A FitzGerald; R Dingledine
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

5.  COX1 and COX2 expression in non-neuronal cellular compartments of the rhesus macaque brain during lentiviral infection.

Authors:  Candan Depboylu; Eberhard Weihe; Lee E Eiden
Journal:  Neurobiol Dis       Date:  2011-01-08       Impact factor: 5.996

6.  Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E2 production in astrocytes.

Authors:  Miriam Font-Nieves; M Glòria Sans-Fons; Roser Gorina; Ester Bonfill-Teixidor; Angélica Salas-Pérdomo; Leonardo Márquez-Kisinousky; Tomàs Santalucia; Anna M Planas
Journal:  J Biol Chem       Date:  2012-01-04       Impact factor: 5.157

7.  Impairment of Rat Spatial Learning and Memory in a New Model of Cold Water-Induced Chronic Hypothermia: Implication for Alzheimer's Disease.

Authors:  Mohammad Mahdi Ahmadian-Attari; Leila Dargahi; Mahmoud Mosaddegh; Mohammad Kamalinejad; Behzad Khallaghi; Fatemeh Noorbala; Abolhassan Ahmadiani
Journal:  Neurotox Res       Date:  2015-03-18       Impact factor: 3.911

8.  COX-1 and COX-2 polymorphisms in susceptibility to cerebral palsy in very preterm infants.

Authors:  Helena Kapitanović Vidak; Tina Catela Ivković; Zoran Vidak; Sanja Kapitanović
Journal:  Mol Neurobiol       Date:  2016-01-19       Impact factor: 5.590

9.  Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier.

Authors:  Nicole A Northrop; Bryan K Yamamoto
Journal:  J Neuroimmune Pharmacol       Date:  2012-07-26       Impact factor: 4.147

10.  Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease.

Authors:  Sang-Ho Choi; Saba Aid; Luca Caracciolo; S Sakura Minami; Takako Niikura; Yasuji Matsuoka; R Scott Turner; Mark P Mattson; Francesca Bosetti
Journal:  J Neurochem       Date:  2012-11-21       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.